Exchange Announcement • 26 Mar 2025 20:01
Exchange Announcement • 31 Jan 2025 11:33
Exchange Announcement • 23 Aug 2024 12:30
Exchange Announcement • 05 Feb 2024 14:09
Exchange Announcement • 26 Jan 2024 21:30
ENTITY
SMARTSCORE: 2.2/5
Evaxion Biotech A/S (EVAX US)
Evaxion Biotech A/S (EVAX US)
14
Analysis
Health Care • Denmark
Evaxion Biotech A/S operates as a biotechnology company. The Company develops AI-immunology platform for decoding human immune system to discover and develop immunotherapies for cancer and infectious diseases treatment. Evaxion Biotech serves patients in Denmark.
morex